Follow on Google News News By Tag Industry News Country(s) Industry News
Follow on Google News | Ajinomoto AminoScience Launches Revolutionary Protein ProcessBreakthrough expression system reduces production costs and speeds time to market.
By: Amy Brown “Ajinomoto’ This advanced technology is Ajinomoto’s answer to a recent analysis of biotechnology manufacturing by BioPlan Associates, a biotechnology marketing research firm in Rockville, Maryland. In the January 2009 study entitled “Genetic Expression Systems: Current and Future Manufacturing Platforms,” the firm outlines the need for advances in manufacturing. The study describes a “reluctance” “This new process shows Ajinomoto’s willingness to invest in scientific efforts to improve expression systems,” says Heaton. “We have answered the industry’s call to develop better technology to meet our customers’ needs.” Ajinomoto, the worlds’ largest manufacturer of amino acids, was the first company in the world to identify, refine and market amino acids. The company is considered the leader in pioneering new technologies and research and development of amino acids. The Raleigh, North Carolina facility, which began production in 1982, is the only U.S. manufacturer of cGMP pharmaceutical grade amino acids. Key applications include use in therapeutic pharmaceutical development, cell culture media, parenteral and clinical nutrition, health foods and food applications. About Ajinomoto AminoScience, LLC: Ajinomoto AminoScience, LLC has a century long heritage of R&D investment and innovation with 50 years of pharmaceutical experience. Today, this company is recognized as the unrivaled leader and premier supplier of pharmaceutical grade amino acids. Ajinomoto created standards that have become the accepted benchmark for the amino acid industry. Since its development, the company has provided a steady supply of high quality amino acids while vigorously pursuing research programs and improving manufacturing processes. Contact: Joel White whitej@ajiusa.com 877-526- End
Account Email Address Disclaimer Report Abuse
|
|